Estimating prevalence of human traits among populations from polygenic risk scores

被引:5
|
作者
Graham, Britney E. [1 ,2 ,3 ,4 ]
Plotkin, Brian [1 ,2 ,3 ]
Muglia, Louis [5 ,6 ]
Moore, Jason H. [7 ]
Williams, Scott M. [1 ,2 ,3 ]
机构
[1] Case Western Reserve Univ, Cleveland Inst Computat Biol, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland Inst Computat Biol, Dept Genet, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Cleveland Inst Computat Biol, Dept Genome Scenes, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Syst Biol & Bioinformat, Cleveland, OH 44106 USA
[5] Burroughs Wellcome Fund, Res Triangle Pk, NC 27614 USA
[6] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[7] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Disease prevalence; PRS transferability; Universal risk variants; Genetic architecture; LACTASE PERSISTENCE ALLELES; MULTIPLE-SCLEROSIS; VITAMIN-D; LOCI; HERITABILITY; DIVERSITY; EPISTASIS; EVOLUTION; VARIANTS; AFRICA;
D O I
10.1186/s40246-021-00370-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The genetic basis of phenotypic variation across populations has not been well explained for most traits. Several factors may cause disparities, from variation in environments to divergent population genetic structure. We hypothesized that a population-level polygenic risk score (PRS) can explain phenotypic variation among geographic populations based solely on risk allele frequencies. We applied a population-specific PRS (psPRS) to 26 populations from the 1000 Genomes to four phenotypes: lactase persistence (LP), melanoma, multiple sclerosis (MS) and height. Our models assumed additive genetic architecture among the polymorphisms in the psPRSs, as is convention. Linear psPRSs explained a significant proportion of trait variance ranging from 0.32 for height in men to 0.88 for melanoma. The best models for LP and height were linear, while those for melanoma and MS were nonlinear. As not all variants in a PRS may confer similar, or even any, risk among diverse populations, we also filtered out SNPs to assess whether variance explained was improved using psPRSs with fewer SNPs. Variance explained usually improved with fewer SNPs in the psPRS and was as high as 0.99 for height in men using only 548 of the initial 4208 SNPs. That reducing SNPs improves psPRSs performance may indicate that missing heritability is partially due to complex architecture that does not mandate additivity, undiscovered variants or spurious associations in the databases. We demonstrated that PRS-based analyses can be used across diverse populations and phenotypes for population prediction and that these comparisons can identify the universal risk variants.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Predicting Behavioural Traits from Polygenic Scores Between and Within Families
    Plomin, Robert J.
    Lin, Yujing
    Procopio, Francesca
    Keser, Engin
    Kawakami, Kaito
    Eley, Thalia C.
    Allegrini, Andrea G.
    Rimfeld, Kaili
    Malanchini, Margherita
    BEHAVIOR GENETICS, 2024, 54 (06) : 491 - 491
  • [32] Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations
    Ozan Dikilitas
    Daniel J. Schaid
    Catherine Tcheandjieu
    Shoa L. Clarke
    Themistocles L. Assimes
    Iftikhar J. Kullo
    Current Cardiology Reports, 2022, 24 : 1169 - 1177
  • [33] The False Dawn of Polygenic Risk Scores for Human Disease Prediction
    Herzig, Anthony F.
    Clerget-Darpoux, Francoise
    Genin, Emmanuelle
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (08):
  • [34] EVALUATING HUMAN BLASTOCYST MORPHOLOGY AND POLYGENIC DISEASE RISK SCORES
    O'Donnell, Jordan
    Widen, Erik
    Xu, Jia
    Alouf, Charlene A.
    Popa, Teodora
    Treff, Nathan R.
    Kristiansen, Mark
    Marin, Diego
    FERTILITY AND STERILITY, 2024, 122 (04) : E45 - E45
  • [35] Bridging the performance gap for underrepresented populations: Anchor regression for polygenic risk scores
    Klinkhammer, Hannah
    Maj, Carlo
    Krawitz, Peter
    Staerk, Christian
    Mayr, Andreas
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1665 - 1665
  • [36] Incorporating family history of disease improves polygenic risk scores in diverse populations
    Hujoel, Margaux L. A.
    Loh, Po-Ru
    Neale, Benjamin M.
    Price, Alkes L.
    CELL GENOMICS, 2022, 2 (07):
  • [37] Validity of cardiovascular polygenic risk scores mostly derived from europeans in multi-ethnic populations
    Topriceanu, Cristian
    Garfield, Victoria
    Mathur, Rohini
    Chaturvedi, Nish
    HEART, 2023, 109 : A219 - A221
  • [38] Application of Europeanspecific polygenic risk scores for predicting prostate cancer risk in different ancestry populations
    Ruan, X.
    Na, R.
    BJU INTERNATIONAL, 2023, 131 : 4 - 4
  • [39] Evaluating polygenic risk scores for predicting cardiometabolic traits and disease risks in the Taiwan Biobank
    Chung, Ren-Hua
    Chuang, Shao-Yuan
    Zhuang, Yong-Sheng
    Jhang, Yi-Syuan
    Huang, Tsung-Hsien
    Li, Guo-Hung
    Chang, I-Shou
    Hsiung, Chao A.
    Chiou, Hung-Yi
    HUMAN GENETICS AND GENOMICS ADVANCES, 2024, 5 (01):
  • [40] Improving trans-ethnic portability of polygenic risk scores with predicted expression traits
    Liang, Yanyu
    Lappalainen, Tuuli
    Manichaikul, Ani
    Palmer, Abraham A.
    Wheeler, Heather
    Im, Hae Kyung
    GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 501 - 501